Observational study shows significant improvement in post-stroke pneumonia using Xiaochaihu and Xiaoxianxiong decoctions, indicating better outcomes compared to standard treatment.
Objective: To investigate the clinical efficacy of Xiaochaihu Decoction combined with Xiaoxianxiong Decoction in the treatment of post-stroke pneumonia. Methods: To complete the sample grouping comparison, all patients with post-stroke pneumonia were investigated, and the number of cases was 60. These patients’ diseases were consistent with the dialectical standards of traditional Chinese medicine (phlegm-heat obstructing lungs). The patients were randomly divided into a control group (30 cases, treated with antibiotics and symptomatic methods) and a treatment group (30 cases, treated with Xiaochaihu Decoction and Xiaoxianxiong Decoction on the basis of the control group). Various indicators were compared. Results: The total clinical effective rates were 93% and 80% in the treatment group and the control group, respectively, with statistical significance (P < 0.05). The improvement of various clinical symptoms was compared, and the values in the treatment group were reduced, showing significance (P < 0.05). Analysis of serum factor indicators showed that the overall trend of the treatment group was reduced, and the comparison between groups was below 0.05. Conclusion: Xiaochaihu Decoction combined with Xiaoxianxiong Decoction has a significant clinical effect in the treatment of post-stroke pneumonia (phlegm-heat obstructing lungs syndrome), which can reduce inflammatory reactions and has few adverse reactions, worthy of clinical application
No takes yet. Share an insight, caveat, or question.
Dai et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: